Toxoplasmic Lymphadenopathy Clinically Presenting as Lymphoma

Gazzinelli R.T. , Denkers E.Y. , Sher A. Host resistance to Toxoplasma gondii: model for studying the selective induction of cell-mediated immunity by intracellular parasites. Infect Agents Dis. 1993; 2: 139–149.

Choi W.Y. , Nam H.W. , Kwak N.H. Foodborne outbreaks of human toxoplasmosis. J Infect Dis. 1997; 175: 1280–1282.

Israelski D.M. , Remington J.S. Toxoplasmosis in patients with cancer. Clin Infect Dis. 1993; 17(suppl 2): S423–S435.

Dubey J.P. A review of toxoplasmosis in pigs. Vet Parasitol. 1986; 19: 181–223.

Herwaldt B.L. , Juranek D.D. Laboratory-acquired malaria, leishmaniasis, trypanosomiasis and toxoplasmosis. Am J Trop Med Hyg. 1993; 48: 313–323.

Dubey J.P. , Beattie C.P. Toxoplasmosis of Animals and Man. Boca Raton, Fla: CRC Press; 1988.

Frenkel J.K. , Hassanein K.M. , Hassanein R.S. Transmission of Toxoplasma gondii in Panama City, Panama: a five-year prospective cohort study of children, cats, rodents, birds, and soil. Am J Trop Med Hyg. 1995; 53: 458–468.

Mullens A. “I think we have a problem in Victoria”: MDs respond quickly to toxoplasmosis outbreak in BC. Can Med Assoc J. 1996; 154: 1721–1724.

O'Connell S. , Guy E.C. , Dawson S.J. Chronic active toxoplasmosis in an immunocompetent patient. J Infect. 1993; 27: 305–310.

Sheagren J.N. , Lunde M.N. , Simon H.B. Chronic lymphadenopathic toxoplasmosis. A case with marked hyperglobulinemia and impaired delayed hypersensitivity responses during active infection. Am J Med. 1976; 60: 300–305.

McCabe R.E. , Brooks R.G. , Dorfman R.F. Clinical spectrum in 107 cases of toxoplasmic lymphadenopathy. Rev Infect Dis. 1987; 9: 754–774.

Mandell G.L. , Douglas , Bennett J.E. Toxoplasma gondii. Principles and Practice of Infectious Diseases. 3rd ed. New York, NY: Churchill Livingstone; 1990: 2455–2471.

Montoya J.G. , Remington J.S. Studies on the serodiagnosis of toxoplasmic lymphadenitis. Clin Infect. Dis. 1995; 20: 781–789.

Kean B.H. Clinical toxoplasmosis: 50 years. Trans R Soc Trop Med Hyg. 1972; 66: 549–571.

Faruqui A.M. , Frank M 3rd , Posvoll R.V. Acute acquired toxoplasmosis. South Med J. 1976; 69: 1234–1235.

Brion J.P. , Pelloux H. , Le Marc'hadour F. Acute toxoplasmic hepatitis in a patient with AIDS. Clin Infect Dis. 1992; 15: 183–184.

Gandhi S. , Lyubsky S. , Jimenez-Lucho V. Adult respiratory distress syndrome associated with disseminated toxoplasmosis. Clin Infect Dis. 1994; 19: 169–171.

Derouin F. , Devergie A. , Auber P. Toxoplasmosis in bone marrow-transplant recipients: report of seven cases and review. Clin Infect Dis. 1992; 15: 267–270.

Remington J. , McLeod R. , Desmonts G. Toxoplasmosis. In: Remington J. , Klein J. , eds. Infectious Diseases of the Fetus and Newborn Infant. 4th ed. Philadelphia, Pa: WB Saunders; 1994.

Montoya J.G. , Remington J.S. Studies on the serodiagnosis of toxoplasmic lymphadenitis. Clin Infect Dis. 1995; 20: 781–789.

Wilson M. , Ware D.A. , Juranek D.D. Serologic aspects of toxoplasmosis. J Am Vet Med Assoc. 1990; 196: 227–281.

Dupouy-Camet J. , Lavereda deSouza S. , Maslo C. Detection of Toxoplasma gondii in venous blood of AIDS patients by polymerase chain reaction. J Clin Microbiol. 1993; 31: 1866–1869.

Hohlfeld P. , Daffos F. , Costa J.M. Prenatal diagnosis of congenital toxoplasmosis with a PCR-test on amniotic fluid. N Engl J Med. 1994; 331: 695–699.

Burg J.L. , Grover C.M. , Pouletty P. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol. 1989; 27: 1787–1792.

Dorfman R.F. , Remington J.S. Value of lymph-node biopsy in the diagnosis of acute acquired toxoplasmosis. N Engl J Med. 1973; 289: 878–881.

Cherin P , Leger-Ravet M.B. , Aznar C. Kikuchi's histiocytic necrotizing lymphadenitis of toxoplasmic origin may be due to a local reactional mechanism in lymph nodes. Clin Infect Dis. 1995; 20: 481–482.

Huskinson-Mark J. , Araujo F.G. , Remington J.S. Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii. J Infect Dis. 1991; 164: 170–171.

Araujo F.G. , Huskinson-Mark J. , Gutterridge W.E. In vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii. Antimicrob Agents Chemother. 1992; 36: 326–330.

Dannemann B. , McCutchan J.A. , Israel-ski D. Treatment of toxoplasmic encephalitis in patients with AIDS: a randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group. Ann Intern Med. 1992; 116: 33–43.